EO2 (ALEO2.PA) Stock Fundamental Analysis

EPA:ALEO2 • FR0010465534

2.58 EUR
-0.06 (-2.27%)
Last: Feb 19, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

2

ALEO2 gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 77 industry peers in the Oil, Gas & Consumable Fuels industry. ALEO2 scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALEO2 has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year ALEO2 has reported negative net income.
  • In the past year ALEO2 had a positive cash flow from operations.
  • ALEO2 had positive earnings in 4 of the past 5 years.
  • ALEO2 had a positive operating cash flow in 4 of the past 5 years.
ALEO2.PA Yearly Net Income VS EBIT VS OCF VS FCFALEO2.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M -4M 6M -6M

1.2 Ratios

  • ALEO2's Return On Assets of -0.23% is on the low side compared to the rest of the industry. ALEO2 is outperformed by 77.92% of its industry peers.
  • With a Return On Equity value of -0.45%, ALEO2 is not doing good in the industry: 77.92% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -0.22%
ROE -0.45%
ROIC N/A
ROA(3y)3.7%
ROA(5y)2.69%
ROE(3y)8.38%
ROE(5y)6.12%
ROIC(3y)N/A
ROIC(5y)N/A
ALEO2.PA Yearly ROA, ROE, ROICALEO2.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20

1.3 Margins

  • With a decent Gross Margin value of 55.94%, ALEO2 is doing good in the industry, outperforming 64.94% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ALEO2 has grown nicely.
  • The Profit Margin and Operating Margin are not available for ALEO2 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.8%
GM growth 5Y19.22%
ALEO2.PA Yearly Profit, Operating, Gross MarginsALEO2.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • ALEO2 does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ALEO2 has about the same amount of shares outstanding.
  • Compared to 5 years ago, ALEO2 has less shares outstanding
  • Compared to 1 year ago, ALEO2 has an improved debt to assets ratio.
ALEO2.PA Yearly Shares OutstandingALEO2.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M 2.5M
ALEO2.PA Yearly Total Debt VS Total AssetsALEO2.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

  • Based on the Altman-Z score of 1.55, we must say that ALEO2 is in the distress zone and has some risk of bankruptcy.
  • ALEO2 has a Altman-Z score of 1.55. This is comparable to the rest of the industry: ALEO2 outperforms 41.56% of its industry peers.
  • A Debt/Equity ratio of 0.36 indicates that ALEO2 is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.36, ALEO2 is doing good in the industry, outperforming 66.23% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z 1.55
ROIC/WACCN/A
WACC5.88%
ALEO2.PA Yearly LT Debt VS Equity VS FCFALEO2.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M 15M 20M

2.3 Liquidity

  • A Current Ratio of 2.14 indicates that ALEO2 has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.14, ALEO2 belongs to the top of the industry, outperforming 84.42% of the companies in the same industry.
  • A Quick Ratio of 1.46 indicates that ALEO2 should not have too much problems paying its short term obligations.
  • ALEO2 has a Quick ratio of 1.46. This is in the better half of the industry: ALEO2 outperforms 77.92% of its industry peers.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio 1.46
ALEO2.PA Yearly Current Assets VS Current LiabilitesALEO2.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • ALEO2 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -642.86%.
  • The Revenue has decreased by -0.28% in the past year.
  • Measured over the past years, ALEO2 shows a small growth in Revenue. The Revenue has been growing by 4.28% on average per year.
EPS 1Y (TTM)-642.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-187.5%
Revenue 1Y (TTM)-0.28%
Revenue growth 3Y-0.53%
Revenue growth 5Y4.28%
Sales Q2Q%1.5%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALEO2.PA Yearly Revenue VS EstimatesALEO2.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALEO2. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALEO2.PA Price Earnings VS Forward Price EarningsALEO2.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • ALEO2's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.83
ALEO2.PA Per share dataALEO2.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ALEO2 does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EO2

EPA:ALEO2 (2/19/2026, 7:00:00 PM)

2.58

-0.06 (-2.27%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners28.33%
Ins Owner ChangeN/A
Market Cap6.19M
Revenue(TTM)30.41M
Net Income(TTM)-90.00K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.21
P/FCF N/A
P/OCF 3.35
P/B 0.29
P/tB 0.32
EV/EBITDA 6.83
EPS(TTM)-0.38
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.38
FCFYN/A
OCF(TTM)0.77
OCFY29.88%
SpS12.57
BVpS8.75
TBVpS8.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.22%
ROE -0.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.94%
FCFM N/A
ROA(3y)3.7%
ROA(5y)2.69%
ROE(3y)8.38%
ROE(5y)6.12%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.8%
GM growth 5Y19.22%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Debt/EBITDA 3.68
Cap/Depr 79.14%
Cap/Sales 9.19%
Interest Coverage N/A
Cash Conversion 93.43%
Profit Quality N/A
Current Ratio 2.14
Quick Ratio 1.46
Altman-Z 1.55
F-Score5
WACC5.88%
ROIC/WACCN/A
Cap/Depr(3y)115.4%
Cap/Depr(5y)96.64%
Cap/Sales(3y)8.27%
Cap/Sales(5y)6.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-642.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-187.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.28%
Revenue growth 3Y-0.53%
Revenue growth 5Y4.28%
Sales Q2Q%1.5%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-480%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y86.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y169.92%
OCF growth 3Y-29.17%
OCF growth 5Y-11.33%

EO2 / ALEO2.PA FAQ

What is the ChartMill fundamental rating of EO2 (ALEO2.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALEO2.PA.


Can you provide the valuation status for EO2?

ChartMill assigns a valuation rating of 0 / 10 to EO2 (ALEO2.PA). This can be considered as Overvalued.


Can you provide the profitability details for EO2?

EO2 (ALEO2.PA) has a profitability rating of 2 / 10.


What is the financial health of EO2 (ALEO2.PA) stock?

The financial health rating of EO2 (ALEO2.PA) is 5 / 10.